18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Malignant Pleural Mesothelioma: What Is the Role in Mesothelioma Detection and Treatment Response Assessment?

Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18F]fluoro-2-deoxyd-glucose (18F-FDG) has emerged as a powerful tool for combined metabolic and anatomic evaluations in clinical oncologic imaging. 18F-FDG PET/CT is also a useful tool to manage patients with malignant pleural mesothelioma, including diagnosis, initial staging, and treatment response assessment. However, a further improvement about PET is desirable.